7/29/2021Complix Signs Global Drug R&D Pact with Nhwa Pharma to Develop Novel A...

7/29/2021Parexel Enters Patient Centric Partnership with CAMS Cancer Hospital

7/29/2021Novita and CR Double Crane in License Deal for Fascin Inhibitor in C...

7/29/2021I-Mab's Chinese IND for P2 Trial of Efineptakin Alfa in Combo with PD-...

7/29/2021Health Care in the Year of the Ox: Navigating China's Dynamic M&A Mark...

7/29/2021China's New Grounds for Defence and Damages Indicates Tougher Rules on...

7/29/2021Antibody Licensing Deals in China: H1 2021 Summary by PharmaDJ/CAS

7/29/2021China's 2021-2025 Five-Year Plan - An Outlook to China's Planned Futur...

7/28/2021NHC Issues the Guidelines for Comprehensive Clinical Appraisal of Drug...

7/28/2021Daewoong Reports Positive Chinese Ph3 Trial Outcome of Its Botulinum...

7/27/2021NMPA Revises Packages Insert of Vitamin B6 Injection

7/27/2021NMPA Issues the Announcement on Certain Matters Related to Drug-Device...

7/27/2021HUTCHMED and AZ Initiate Phase II Trial of ORPATHYS for MET Amplified ...

7/27/2021NASDAQ-listed I-Mab to Seek Dual Listing on Shanghai's STAR Market

7/27/2021Sanofi Secures A New Indication for Renvela (sevelamer) in China

7/27/2021Set Up Steps for Biotech Businesses in China

7/27/2021Understanding "Internet Plus Healthcare" in China: Policy Text Analysi...

7/23/2021Novartis Reports Strong H1 & Q2 Global and China Performance

7/23/2021Roche Reports Flat H1 Performance with Moderate China Drug Sales Growt...

7/23/2021CDE Solicits Comments on the Technical Guidelines for Preparing the Ri...

7/23/2021CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...

7/23/2021Menarini AP Acquires China Rights of Cialis (Tadalafil) from Lilly

7/23/2021NMPA Issues the List of Reference Formulations for GQCE Studies (43nd ...

7/23/2021Recent Executive Moves

7/22/2021AI Drug Firm Insilico Mulls IPO in the U.S.

7/22/2021RareStone Submits Chinese NDA of Wakix (pitolisant) for Narcolepsy in ...

7/22/2021Exscientia and GT Apeiron Therapeutics Enter Strategic Oncology R&D Pa...

7/22/2021CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...

7/22/2021Aptamer and WuXi AppTec Collaborate to Identify New Optimer Enabled Th...

7/22/2021Merck and Adagene Ink Trial Collaboration and Supply Agreement for Com...

Page:205/802 Total number of articles:24058: [First][<<] [203] [204] [205] [206] [207] [>>] [End]